Donors and drug makers offer $500 million to control global epidemics

A group of donors and pharmaceutical companies has teamed up to help stop global epidemics. The Coalition for Epidemic Preparedness Innovations (CEPI), funded by nearly $500 million, will first focus on developing and stockpiling vaccines against three known viral threats, and further the development of technology to quickly make large amounts of...

A group of donors and pharmaceutical companies has teamed up to help stop global epidemics. The Coalition for Epidemic Preparedness Innovations (CEPI), funded by nearly $500 million, will first focus on developing and stockpiling vaccines against three known viral threats, and further the development of technology to quickly make large amounts of vaccine when new threats appear. The coalition will initially work to further development of vaccines against Lassa fever, the Nipah virus, and Middle East Respiratory Syndrome. Donors for the new coalition include the Gates Foundation, the governments of Japan and Norway, and the Wellcome Trust in England. In addition, six major vaccine makers joined the coalition as partners, as did the World Health Organization and Doctors Without Borders. CEPI was announced at the World Economic Forum in Davos, Switzerland.